Clinical Analysis of TACE Combined with PSE Treating Hepatocellular Carcinoma with Hypersplenism

Objective 　To observe clinical value and complication of treatment primary hepatocelluar carcinoma ( HCC) with hypersplenism by using transcatheter arterial chemombolization ( TACE) combined ith partial splenic embolization ( PSE) . Methods 　37 patients with hypersplenism were t reated by TACE and PSE to observe the degree for reduction of tumor volume and remission of hypersplenism and incidence of complications. Results 　Tumor reduction rate of HCC patient s was 70. 3 %. After treating two eeks and one month, the emission rate of hypersplenism patients was 89. 2 % and 78. 4 % respectively.There was no severe complication such as hypatic abscess. Conclusion 　TACE combined with PSE is a safe and effective method to treat HCC with hypersplenism.